Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

British pharmaceutical company GSK PLC (GSK) and its Massachusetts-based partner Spero Therapeutics (SPRO) said on Wednesday ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

TAR-200 demonstrated high DFS and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer with papillary-only disease. The phase 2b SunRISe-1 study showed over 80% ...

Geriatric patients and patients with clinically significant bladder outlet obstruction and ... Decreased Gastrointestinal Motility: COBENFY contains trospium chloride. Trospium chloride, like ...

This causes tiredness during the day and decreases, not only work ... bladder capacity can lead to more frequent urination. Anticholineric agents like Darifenacin, Oxybutynin, Tolterodine ...

Findings from a new study led by Flinders University's Dr. Luke Grundy and SAHMRI's Dr. Steven Taylor shows that UTIs cause the nerves in the bladder to become hypersensitive, resulting in the ...

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or returning to patients, according to a new study. Published in the New ...

But those on darifenacin, fesoterodine fumarate, flavoxate hydrochloride, propiverine hydrochloride, and trospium ... work, it can also mean the urine is more concentrated, which irritates the ...